Aptorum Group Limited announced the commercial launch of NativusWell, a new dietary supplement supporting women's health throughout the Menopausal period. NativusWell is distributed via HKTV Mall and NativusWell official website https://nativuswell.com/by Nativus Life Sciences Limited, a wholly-owned subsidiary of Aptorum Group. Menopause is experienced by women starting from the 40s that influences both physical and mental health.

The global menopause market size was valued at USD 15.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.29% from 2022 to 2030. The dietary supplements segment dominated the market in terms of revenue share in 2020 and is expected to witness the fastest growth over the forecast period. The factors contributing to segment growth are a large number of women entering menopause every year and the launch of innovative products.

NativusWell contains a novel, non-hormonal bioactive ingredient DOI, designed to support the overall health of women undergoing perimenopause, menopause and postmenopause. Research has found that NativusWell has anti-ageing and antioxidant effect and is able to show to support bone health. The product is now available on HKTV Mall, a leading online shopping mall in Hong Kong, and also on website.

Ecommerce has experienced a great increase in sales performance since 2020. In 2021, HKTV Mall has reached 1,287,000 unique customers. By leveraging high traffic recorded and large consumer base in HKTV Mall, and the company's expansion of other distribution channels, Aptorum Group believes it will be able to reach an extensive network of target customers in Hong Kong.

Registration and distribution of NativusWell in the US, EU, UK and China are being progressed in parallel as part of Nativus' ongoing global commercialization efforts.